15 Apr 2019 --- Innexus Nutraceuticals, based in the Netherlands, has landed a distribution deal with IMCD, a global player in sales, marketing and distribution of specialty chemicals and food ingredients. The partnership will focus on reaching European supplement manufacturers, excluding Scandinavia, for Innexus’ palmitoylethanolamide (PEA) ingredient. “OptiPEA is a viable alternative to cannabidiol (CBD) products, as there are no regulatory issues and it is easier to formulate,” Samuel Zonneveld, Innexus CEO tells NutritionInsight.
